FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Anna Nowak

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Anatomy

CD8-Positive T-Lymphocytes

Living Beings

Co-author Network

Publications

TOP 3
Zacariah E Labby; Samuel G Armato; James J Dignam; Hedy L Kindler; Christopher Straus; Anna K Nowak
Lung volume measurements as a surrogate marker for patient response in malignant pleural mesothelioma.
Daniel E Schwed Lustgarten; Anna K Nowak; Vassiliki Saloura; Giulia Stella; Anil Vachani; Liang-Chuan Wang; Li-Ping Wang; Jenette Creaney; Charuhas Deshpande; Michael Feldman; Simona Inghilleri; Corey Langer; Leslie Litzky; Charu Aggarwal; Steven M Albelda
Thymidylate synthase and folyl-polyglutamate synthase are not clinically useful markers of response to pemetrexed in patients with malignant pleural mesothelioma.
Jenette Creaney; Hanne Dare; Yvonne Demelker; Ian M Dick; Arthur William Musk; Anna K Nowak; Bruce W S Robinson
Does CA125 binding to mesothelin impact the detection of malignant mesothelioma?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Anna Nowak (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Zacariah E Labby; Samuel G Armato; James J Dignam; Hedy L Kindler; Christopher Straus; Anna K Nowak
Lung volume measurements as a surrogate marker for patient response in malignant pleural mesothelioma.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2013;8(4):478-86.
2013: Daniel E Schwed Lustgarten; Anna K Nowak; Vassiliki Saloura; Giulia Stella; Anil Vachani; Liang-Chuan Wang; Li-Ping Wang; Jenette Creaney; Charuhas Deshpande; Michael Feldman; Simona Inghilleri; Corey Langer; Leslie Litzky; Charu Aggarwal; Steven M Albelda
Thymidylate synthase and folyl-polyglutamate synthase are not clinically useful markers of response to pemetrexed in patients with malignant pleural mesothelioma.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2013;8(4):469-77.
2013: Jenette Creaney; Hanne Dare; Yvonne Demelker; Ian M Dick; Arthur William Musk; Anna K Nowak; Bruce W S Robinson
Does CA125 binding to mesothelin impact the detection of malignant mesothelioma?
Lung cancer (Amsterdam, Netherlands) 2013;80(1):39-44.
2013: Z E Labby; Anna K Nowak; C Straus; J J Dignam; H L Kindler; Samuel G Armato
Disease volumes as a marker for patient response in malignant pleural mesothelioma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2013;24(4):999-1005.
2013: Melanie J McCoy; Anna K Nowak; Robbert G van der Most; Ian M Dick; Richard A Lake
Peripheral CD8(+) T cell proliferation is prognostic for patients with advanced thoracic malignancies.
Cancer immunology, immunotherapy : CII 2013;62(3):529-39.
2013: W Joost Lesterhuis; Anna K Nowak; Bruce W Robinson; Esdy N Rozali; Joanne Salmons; Ian M Dick; Julie A Harken; Andrea Khong; Richard A Lake
Synergistic effect of ctla-4 blockade and cancer chemotherapy in the induction of anti-tumor immunity.
PloS one 2013;8(4):e61895.
2013: Amanda Segal; Keith B Shilkin; Gregory F Sterrett; Felicity A Frost; Arthur William Musk; Anna K Nowak; Nola J Olsen; Bruce William S Robinson; Jenette Creaney
A diagnosis of malignant pleural mesothelioma can be made by effusion cytology: results of a 20 year audit.
Pathology 2013;45(1):44-8.
2012: Zacariah E Labby; Samuel G Armato; James J Dignam; Arman Hasani; Hedy L Kindler; Anna K Nowak
Optimization of response classification criteria for patients with malignant pleural mesothelioma.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2012;7(11):1728-34.
2012: M J McCoy; I M Dick; R A Lake; R G van der Most; Anna K Nowak
Post-chemotherapy T-cell recovery is a marker of improved survival in patients with advanced thoracic malignancies.
British journal of cancer 2012;107(7):1107-15.
2012: Anna K Nowak; Amanda Segal; Agatha van der Schaaf; Jenette Creaney; Ian M Dick; Roslyn J Francis; Arman Hasani; Michael J Millward; Arthur W Musk; Michael J Byrne
A phase II study of intermittent sunitinib malate as second-line therapy in progressive malignant pleural mesothelioma.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2012;7(9):1449-56.
2012: Andrea Khong; Richard A Lake; Delia J Nelson; Anna K Nowak; Bruce W S Robinson
The use of agonistic anti-CD40 therapy in treatments for cancer.
International reviews of immunology 2012;31(4):246-66.
2012: Cleo Robinson; Amy Walsh; Samantha Woo; Anna K Nowak; Richard A Lake
The antioxidants vitamins A and E and selenium do not reduce the incidence of asbestos-induced disease in a mouse model of mesothelioma.
Nutrition and cancer 2012;64(2):315-22.
2011: Martin R Stockler; Guy Van Hazel; Nicholas Wilcken; Diana Zannino; Stephen P Ackland; Michael J Byrne; Bernie Fitzharris; Akiko Fong; John F Forbes; Prudence A Francis; M Corona Gainford; Val Gebski; Peter S Grimison; Vernon J Harvey; Anna K Nowak; Lisa Paksec; R John Simes; Tatiana Sourjina; Alan S Coates
Capecitabine versus classical cyclophosphamide, methotrexate, and fluorouracil as first-line chemotherapy for advanced breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(34):4498-504.
2011: Alison M McDonnell; Anna K Nowak; Richard A Lake
Contribution of the immune system to the chemotherapeutic response.
Seminars in immunopathology 2011;33(4):353-67.
2011: Mamta Bagia; Anna K Nowak
Novel targeted therapies and vaccination strategies for mesothelioma.
Current treatment options in oncology 2011;12(2):149-62.
2011: Prunella Blinman; Sue-Anne McLachlan; Anna K Nowak; Vlatka M Duric; Chris Brown; Gavin Wright; Michael J Millward; Kwun Fong; Martin R Stockler
Lung cancer clinicians' preferences for adjuvant chemotherapy in non-small-cell lung cancer: what makes it worthwhile?
Lung cancer (Amsterdam, Netherlands) 2011;72(2):213-8.
2011: Jenette Creaney; Roslyn J Francis; Ian M Dick; Arthur W Musk; Bruce W S Robinson; Michael J Byrne; Anna K Nowak
Serum soluble mesothelin concentrations in malignant pleural mesothelioma: relationship to tumor volume, clinical stage and changes in tumor burden.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(5):1181-9.
2011: Anna K Nowak; J E Maujean; M Jackson; Neville W Knuckey
A prospective study of surgical patterns of care for high grade glioma in the current era of multimodality therapy.
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2011;18(2):227-31.
2011: Cleo Robinson; Amy Walsh; Irma Larma; Sean O'Halloran; Anna K Nowak; Richard A Lake
MexTAg mice exposed to asbestos develop cancer that faithfully replicates key features of the pathogenesis of human mesothelioma.
European journal of cancer (Oxford, England : 1990) 2011;47(1):151-61.
2010: H J Steer; R A Lake; Anna K Nowak; B W S Robinson
Harnessing the immune response to treat cancer.
Oncogene 2010;29(48):6301-13.
2010: Anna K Nowak; Samuel G Armato; Giovanni Luca Ceresoli; Huseyin Yildirim; Roslyn J Francis
Imaging in pleural mesothelioma: a review of imaging research presented at the 9th International Meeting of the International Mesothelioma Interest Group.
Lung cancer (Amsterdam, Netherlands) 2010;70(1):1-6.
2010: Prunella Blinman; Vlatka M Duric; Anna K Nowak; Philip Beale; Stephen Clarke; Karen Briscoe; Adam Boyce; David Goldstein; Malcolm Hudson; Martin R Stockler
Adjuvant chemotherapy for early colon cancer: what survival benefits make it worthwhile?
European journal of cancer (Oxford, England : 1990) 2010;46(10):1800-7.
2010: Anna K Nowak; Roslyn J Francis; Michael J Phillips; Michael J Millward; Agatha A van der Schaaf; Jan Boucek; Arthur W Musk; Melanie J McCoy; Amanda Segal; Peter Robins; Michael J Byrne
A novel prognostic model for malignant mesothelioma incorporating quantitative FDG-PET imaging with clinical parameters.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(8):2409-17.
2009: Arman Hasani; John M Alvarez; Jenny Ma Wyatt; Sean A Bydder; Michael Millward; Michael Byrne; Arthur W Bill Musk; Anna K Nowak
Outcome for patients with malignant pleural mesothelioma referred for Trimodality therapy in Western Australia.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2009;4(8):1010-6.
2009: Robbert G van der Most; Andrew J Currie; Sathish Mahendran; Amy Prosser; Anna Darabi; Bruce W S Robinson; Anna K Nowak; Richard A Lake
Tumor eradication after cyclophosphamide depends on concurrent depletion of regulatory T cells: a role for cycling TNFR2-expressing effector-suppressor T cells in limiting effective chemotherapy.
Cancer immunology, immunotherapy : CII 2009;58(8):1219-28.
2009: M J McCoy; Anna K Nowak; Richard A Lake
Chemoimmunotherapy: an emerging strategy for the treatment of malignant mesothelioma.
Tissue antigens 2009;74(1):1-10.
2009: Robbert G van der Most; Andrew J Currie; Amanda L Cleaver; Joanne Salmons; Anna K Nowak; Sathish Mahendran; Irma Larma; Amy Prosser; Bruce W S Robinson; Mark J Smyth; Anthony A Scalzo; Mariapia A Degli-Esposti; Richard A Lake
Cyclophosphamide chemotherapy sensitizes tumor cells to TRAIL-dependent CD8 T cell-mediated immune attack resulting in suppression of tumor growth.
PloS one 2009;4(9):e6982.
2008: Jenette Creaney; Amanda Segal; Gregory F Sterrett; M A Platten; E Baker; Ashleigh Murch; Anna K Nowak; Bruce W S Robinson; M J Millward
Overexpression and altered glycosylation of MUC1 in malignant mesothelioma.
British journal of cancer 2008;98(9):1562-9.
2007: Kynan Feeney; Michael Cain; Anna K Nowak
Chemotherapy induced nausea and vomiting--prevention and treatment.
Australian family physician 2007;36(9):702-6.
2007: Roslyn J Francis; Michael J Byrne; Agatha A van der Schaaf; Jan A Boucek; Anna K Nowak; Michael Phillips; Richard Price; Andrew Patrikeos; A William Musk; Michael J Millward
Early prediction of response to chemotherapy and survival in malignant pleural mesothelioma using a novel semiautomated 3-dimensional volume-based analysis of serial 18F-FDG PET scans.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007;48(9):1449-58.
2007: Martin R Stockler; Rachel O'Connell; Anna K Nowak; David Goldstein; Jane Turner; Nicholas Wilcken; david wyld; Ehtesham A Abdi; Amanda Glasgow; Philip Beale; Michael Jefford; Haryana Dhillon; Stephane Heritier; Candace Carter; Ian B Hickie; R John Simes
Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial.
The lancet oncology 2007;8(7):603-12.
2007: T Ferguson; Nicholas Wilcken; R Vagg; Davina Ghersi; Anna K Nowak
Taxanes for adjuvant treatment of early breast cancer.
Cochrane database of systematic reviews (Online) 2007;(4):CD004421.
2006: Anna K Nowak; Richard A Lake; Bruce W S Robinson
Combined chemoimmunotherapy of solid tumours: improving vaccines?
Advanced drug delivery reviews 2006;58(8):975-90.
2005: Anna K Nowak
Phase II trials in mesothelioma: an increasing challenge.
Lung cancer (Amsterdam, Netherlands) 2005;50(1):87-90.
2005: Anna K Nowak; Michael J Byrne
Cisplatin and gemcitabine in malignant mesothelioma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(10):1711.
2005: Anna K Nowak
CT, RECIST, and malignant pleural mesothelioma.
Lung cancer (Amsterdam, Netherlands) 2005;49 Suppl 1():S37-40.
2005: Anna K Nowak
Clinical trials in malignant pleural mesothelioma in Australasia.
Lung cancer (Amsterdam, Netherlands) 2005;49 Suppl 1():S113-6.
2005: Anna K Nowak; Martin R Stockler; Pierce Chow; Michael Findlay
Use of tamoxifen in advanced-stage hepatocellular carcinoma. A systematic review.
Cancer 2005;103(7):1408-14.
2004: Anna K Nowak; Michael J Byrne; Michael J Millward; John M Alvarez; Bruce W S Robinson
Current chemotherapeutic treatment of malignant pleural mesothelioma.
Expert opinion on pharmacotherapy 2004;5(12):2441-9.
2004: Anna K Nowak; Martin R Stockler; Michael J Byrne
Assessing quality of life during chemotherapy for pleural mesothelioma: feasibility, validity, and results of using the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire and Lung Cancer Module.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(15):3172-80.
2004: Anna K Nowak; Pierce Chow; Michael Findlay
Systemic therapy for advanced hepatocellular carcinoma: a review.
European journal of cancer (Oxford, England : 1990) 2004;40(10):1474-84.
2004: Anna K Nowak; Nicholas Wilcken; Martin R Stockler; A Hamilton; Davina Ghersi
Systematic review of taxane-containing versus non-taxane-containing regimens for adjuvant and neoadjuvant treatment of early breast cancer.
The lancet oncology 2004;5(6):372-80.
2004: Michael J Byrne; Anna K Nowak
Modified RECIST criteria for assessment of response in malignant pleural mesothelioma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(2):257-60.
2003: Anna K Nowak; Bruce W S Robinson; Richard A Lake
Synergy between chemotherapy and immunotherapy in the treatment of established murine solid tumors.
Cancer research 2003;63(15):4490-6.
2003: Anna K Nowak; Richard A Lake; Amanda L Marzo; Bernadette Scott; William R Heath; Edward J Collins; Jeffrey Frelinger; Bruce W S Robinson
Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cells.
Journal of immunology (Baltimore, Md. : 1950) 2003;170(10):4905-13.
2002: Anna K Nowak; Michael J Byrne; R Williamson; G Ryan; A Segal; D Fielding; P Mitchell; A William Musk; Bruce W S Robinson
A multicentre phase II study of cisplatin and gemcitabine for malignant mesothelioma.
British journal of cancer 2002;87(5):491-6.
2002: Anna K Nowak; Bruce W S Robinson; Richard A Lake
Gemcitabine exerts a selective effect on the humoral immune response: implications for combination chemo-immunotherapy.
Cancer research 2002;62(8):2353-8.
2002: Anna K Nowak; Richard A Lake; Hedy L Kindler; Bruce W S Robinson
New approaches for mesothelioma: biologics, vaccines, gene therapy, and other novel agents.
Seminars in oncology 2002;29(1):82-96.